Table 1 Baseline characteristics of the participants, prior experience of early detection for PCa and compliance with the study protocol.

From: Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial

 

Arm A

Arm B

Arm C

Arm D

DA-CC

DA-noCC

noDA-CC

noDA-noCC

n = 296

n = 223

n = 271

n = 172

Baseline characteristics of the participants

Median age years (range)

61 (55–69)

61 (55–69)

60 (55–69)

61 (55–69)

In relationship n(%)

256 (90)

202 (93)

249 (93)

148 (89)

German nationality n(%)

279 (98)

216 (99)

266 (99)

167 (100)

Self-assessment of health as “good”a n(%)

200 (70)

141 (66)

173 (67)

112 (68)

Prior experience of early detection of prostate cancer

DRE only n(%)

54 (20)

31 (15)

26 (10)

35 (22)

PSA test only n(%)

17 (6)

18 (9)

11 (4)

10 (6)

DRE and PSA test n(%)

173 (64)

127 (61)

199 (79)

99 (62)

PSA experience in general n(%)

190 (70)

145 (70)

210 (83)

109 (69)

Never had a PSA test n(%)

80 (30)

63 (30)

43 (17)

50 (31)

No prior experience with early detection n(%)

26 (10)

32 (15)

17 (7)

15 (9)

Frequency of previous early detection

1 n(%)

27 (11)

27 (16)

31 (13)

15 (11)

2–3 n(%)

76 (31)

65 (37)

61 (26)

31 (22)

 > 3 n(%)

140 (58)

82 (47)

144 (61)

97 (68)

Compliance with the study protocol

Completed questionnaire at T0 n(%)

283 (99)

215 (99)

263 (98)

163 (98)

Completed telephone interview at T1 n(%)

275 (96)

211 (97)

261 (97)

159 (95)

No relevant protocol deviations n(%)

272 (95)

207 (95)

258 (96)

152 (91)

  1. a5-point scale with answer options: “excellent”, “very good”, “good”, “less good”, “bad”. “Good” was placed in the middle.
  2. PSA prostate specific antigen, DRE digital rectal examination, T0 directly after consultation, T1 two weeks after consultation.